Dr Rea Bingula

College position:

College Research Associate

Rea Bingula
Rea Bingula

Dr Rea Bingula is a Postdoctoral Research Associate at Cambridge Institute of Therapeutic Immunology and Infectious Disease.  As a part of Dr Virginia Pedicord’s lab, her main focus is exploring the mechanism by which a specific bacterial metabolite, lipopolysaccharide, improves the response to cancer immunotherapy.

Dr Bingula obtained her MSc in molecular biology and biotechnology jointly from University of Zagreb, Croatia, and University of Orléans, France.  In 2019, she was awarded a PhD in Biology & Health from University Clermont Auvergne, France.  There, she studied both gut and lung microbiota in lung cancer patients and their link with immune response. This was followed by a 2-year position as Research and Lecture Assistant in biochemistry and molecular biology at Faculty of Pharmacy, University Clermont Auvergne, before starting a PostDoc focusing on immune response post-vaccination against SARS-CoV-2 (UMR1019 UNH, France).

Links to online publications, articles or other work

Selected key publications (complete list can be found here)

Bingula, R., Chabrolles, H., Bonnet, B., Archimbaud, C., Brebion, A., Cosme, J., Ollier, A., Dutheil, F., Junda, M., Mirand, A., Regagnon, C., Vidal, M., Henquell, C., & Evrard, B. (2023). Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection. Emerging Microbes and Infections (Vol. 12, Issue 1). https://doi.org/10.1080/22221751.2023.2184176

Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023). Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. International Journal of Molecular Sciences, 24(4), 4002. https://doi.org/10.3390/ijms24044002

Bingula, R., Filaire, E., Molnar, I., Delmas, E., Berthon, J. Y., Vasson, M. P., Bernalier-Donadille, A., & Filaire, M. (2020). Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: A cross-sectional clinical trial. BMC Respiratory Research, 21(1). https://doi.org/10.1186/s12931-020-01392-2

Bingula, R., Filaire, M., Radosevic-Robin, N., Bey, M., Berthon, J.-Y., Bernalier-Donadille, A., Vasson, M.-P., & Filaire, E. (2017). Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer. Journal of Oncology, 2017, 1–15. https://doi.org/10.1155/2017/5035371

Bingula, R., Dupuis, C., Pichon, C., Berthon, J.-Y. Y., Filaire, M., Pigeon, L., & Filaire, E. (2016). Study of the Effects of Betaine and/or C-Phycocyanin on the Growth of Lung Cancer A549 Cells In Vitro and In Vivo. Journal of Oncology, 2016, 1–11. https://doi.org/10.1155/2016/8162952

2
3